Remove journals pharmaceutical-technology pharmaceutical-technology-october-2022
article thumbnail

Beta Bionics’ automated insulin delivery system picks up manufacturing partner

Pharmaceutical Technology

CGM has become increasingly popular as technological advancements continue to facilitate easier health management. A report from October 2022 published in the British Medical Journal found that insulin access inequity is widespread, with many low-income countries having limited access to the drug.

article thumbnail

Patents: a necessary evil?

European Pharmaceutical Review

Patents are often described as the ‘lifeblood’ of pharmaceutical companies. 1 However, patent protection for pharmaceutical products is an economic trade-off between providing monopoly rights that incentivise development of future products and permitting higher drug prices to recoup the investment. Cited 25 September 2022].

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The ins and outs of the life sciences: top hires for October 2022 

pharmaphorum

As we continue to enter new markets, grow within our existing markets and reach a broader population, we continue to invest in our operations, talent and technology capabilities to support that growth.” ” Jill Howe, Lineage Cell Therapeutics. ” Patrick Genestin, 1910 Genetics .

article thumbnail

Economics and risks of FDA’s Quality management maturity rating programme

European Pharmaceutical Review

The US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) through the Office of Pharmaceutical Quality in 2021 embarked on an initiative to develop a framework for establishing a pharmaceutical manufacturing site quality rating system, the Quality management maturity (QMM) programme.

article thumbnail

How Balancing Iron Levels Can Help Your Thyroid

The Thyroid Pharmacist

42] In a smaller 2022 study, 13 non-professional female athletes were evaluated for iron deficiency. The β-lactoglobulin is the most allergenic, but there is emerging technology that allows companies to isolate the lactoferrin and remove the β-lactoglobulin. [72] Published 2022 Aug 23. World Journal of Gastroenterology.

article thumbnail

Regeneron’s Inmazeb named Galien’s Best Biotech Product

pharmaphorum

The Galien Foundation, which acknowledges “extraordinary scientific innovations that improve the human condition”, has awarded its Best Biotechnology Product 2022 accolade to Regeneron Pharmaceuticals, Inc.’s Those technologies included the VelocImmune mouse and the VelociSuite.